SOLIQUA 100/33 is an injectable treatment that goes beyond what insulins can do alone when used with diet and exercise. It combines two medicines that work together in a single, once-daily dose to deliver proven A1c reduction.
2 medicines work together in a single pen
- Lantus® (insulin glargine injection) 100 Units/mL — a long-acting insulin
- Adlyxin® (lixisenatide injection) — a non-insulin glucagon-like peptide-1 receptor agonist (GLP-1 RA)